The role of cell surface heparan sulfate in enterovirus A71 infections and the development of antiviral agents targeting viral attachment and RNA translation initiation / Tan Chee Wah
Enterovirus A71 (EV-A71) is the main causative agent of hand, foot and mouth disease (HFMD). Recent EV-A71 outbreaks in Asia-Pacific were not limited to mild HFMD, but were associated with neurological complications including aseptic meningitis, brainstem encephalitis and deaths. The absence of l...
| Main Author: | Tan, Chee Wah |
|---|---|
| Format: | Thesis |
| Published: |
2014
|
| Subjects: | |
| Online Access: | http://studentsrepo.um.edu.my/4619/ http://studentsrepo.um.edu.my/4619/1/Tan_Chee_Wah_PhD_Thesis.pdf |
Similar Items
Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor
by: Tan, Chee Wah, et al.
Published: (2013)
by: Tan, Chee Wah, et al.
Published: (2013)
In vitro evaluation of the antiviral activity of heparan sulfate mimetic compounds against Enterovirus 71
by: Pourianfar, Hamid Reza, et al.
Published: (2012)
by: Pourianfar, Hamid Reza, et al.
Published: (2012)
Development of novel miRNA-based vaccines and antivirals against Enterovirus 71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2016)
by: Yee, Isabel Pin Tsin *, et al.
Published: (2016)
Development of antivirals and vaccines against enterovirus 71 (EV-A71)
by: Poh, Chit Laa *
Published: (2018)
by: Poh, Chit Laa *
Published: (2018)
Flavonoids as antiviral agents for Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2020)
by: Lalani, S.*, et al.
Published: (2020)
Functional insights into Silymarin as an antiviral agent against Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2021)
by: Lalani, S.*, et al.
Published: (2021)
Inhibition of Enterovirus 71 (EV-71 infections by a novel
antiviral peptide derived from EV-71 capsid protein VP1
by: Tan, Chee Wah, et al.
Published: (2012)
by: Tan, Chee Wah, et al.
Published: (2012)
Viral transmission, neuropathogenesis and therapeutic antibody studies in a murine model of enterovirus 71 encephalomyelitis / Tan Soon Hao
by: Tan, Soon Hao
Published: (2017)
by: Tan, Soon Hao
Published: (2017)
Enterovirus 71 encephalomyelitis and Japanese encephalitis can be distinguished by topographic distribution of inflammation and specific intraneuronal detection of viral antigen and RNA
by: Wong, K.T., et al.
Published: (2012)
by: Wong, K.T., et al.
Published: (2012)
In silico and in vitro antiviral activity evaluation of prodigiosin from Serratia marcescens against enterovirus 71
by: Muhamad Fakrulnizam Abd Aziz,, et al.
Published: (2022)
by: Muhamad Fakrulnizam Abd Aziz,, et al.
Published: (2022)
Identification of mimotopes of human enterovirus 71
by: Yee, Siew Fung.
Published: (2007)
by: Yee, Siew Fung.
Published: (2007)
The cellular attachment and entry of human enterovirus 71: the role of glycosaminoglycans and evidence for a second receptor
by: Williams, David, et al.
Published: (2009)
by: Williams, David, et al.
Published: (2009)
AIM2 Inflammasome-Mediated Pyroptosis in Enterovirus A71-Infected Neuronal Cells Restricts Viral Replication
by: Yogarajah, Thinesshwary, et al.
Published: (2017)
by: Yogarajah, Thinesshwary, et al.
Published: (2017)
Development of novel vaccines against Enterovirus-71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2015)
by: Yee, Isabel Pin Tsin *, et al.
Published: (2015)
Clinical features, diagnosis, and management of enterovirus 71
by: Ooi, Mong How, et al.
Published: (2010)
by: Ooi, Mong How, et al.
Published: (2010)
Virology, epidemiology, pathogenesis, and control of enterovirus 71.
by: Solomon, Tom, et al.
Published: (2010)
by: Solomon, Tom, et al.
Published: (2010)
Circular antiviral RNA
by: Omar, Abdul Rahman, et al.
Published: (2012)
by: Omar, Abdul Rahman, et al.
Published: (2012)
Beta-actin variant is necessary for Enterovirus 71 replication
by: Lui, Edmund Yan Long, et al.
Published: (2013)
by: Lui, Edmund Yan Long, et al.
Published: (2013)
Impact of genetic changes in the Enterovirus 71 genome on virulence
by: Poh, Chit Laa *, et al.
Published: (2019)
by: Poh, Chit Laa *, et al.
Published: (2019)
Development of a Deoxyribonucleic Acid Vaccine Against Enterovirus 71
by: Wong, Siew Tung
Published: (2005)
by: Wong, Siew Tung
Published: (2005)
Rethinking the teaching of the `Be' passive / Tan Lee Wah
by: Tan, Lee Wah
Published: (1994)
by: Tan, Lee Wah
Published: (1994)
Incorrect identification of recent Asian strains of Coxsackievirus A16 as human enterovirus 71: Improved primers for the specific detection of human enterovirus 71 by RT PCR
by: David, Perera, et al.
Published: (2004)
by: David, Perera, et al.
Published: (2004)
Molecular docking of SP40 peptide towards cellular
receptors for enterovirus 71 (EV-A71)
by: Masomian, Malihe *, et al.
Published: (2021)
by: Masomian, Malihe *, et al.
Published: (2021)
Heparin/heparan sulphate-based drugs
by: Gandhi, Neha, et al.
Published: (2010)
by: Gandhi, Neha, et al.
Published: (2010)
Identification of molecular determinants of cell culture growth characteristics of Enterovirus 71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2016)
by: Yee, Isabel Pin Tsin *, et al.
Published: (2016)
T Cell immunity to enterovirus 71 infection in humans and implications for vaccine development
by: Yee, Isabel Pin Tsin *, et al.
Published: (2018)
by: Yee, Isabel Pin Tsin *, et al.
Published: (2018)
Recombinant human enterovirus 71 in hand, foot and mouth disease patients
by: Yoke, Fun Chan, et al.
Published: (2004)
by: Yoke, Fun Chan, et al.
Published: (2004)
Factors affecting expression and solubility of Enterovirus 71 VP1 protein
by: Ahmad Hafad, Fathimah Azzahroh
Published: (2016)
by: Ahmad Hafad, Fathimah Azzahroh
Published: (2016)
The expression of recombinant
bacille calmette-guerin (rBCG) containing
VPI gene of enterovirus 71 (EV71)
by: Wey, Goh Kai
Published: (2008)
by: Wey, Goh Kai
Published: (2008)
Antiviral activity of silymarin in comparison with baicalein against EV-A71
by: Lalani, S.*, et al.
Published: (2020)
by: Lalani, S.*, et al.
Published: (2020)
Impact of genetic changes, pathogenicity and antigenicity on Enterovirus- A71 vaccine development
by: Yee, Isabel Pin Tsin *, et al.
Published: (2017)
by: Yee, Isabel Pin Tsin *, et al.
Published: (2017)
Development of a diagnostic tool for the detection of antibodies against human enterovirus 71
by: Tan, Cheng Siang.
Published: (2004)
by: Tan, Cheng Siang.
Published: (2004)
Immunogenicity of soluble enterovirus 71 recombinant VP1 protein in mice model
by: Mustafa, Suhaili
Published: (2017)
by: Mustafa, Suhaili
Published: (2017)
Cross-reactive neutralizing antibody epitopes against Enterovirus 71 identified by an in silico approach
by: Kirk, Kristin, et al.
Published: (2012)
by: Kirk, Kristin, et al.
Published: (2012)
A generic assay for whole-genome amplification and deep sequencingof enterovirus A71
by: Le, Van Tan, et al.
Published: (2015)
by: Le, Van Tan, et al.
Published: (2015)
A generic assay for whole-genome amplification and deep sequencing of enterovirus A71
by: Tan, Le Van, et al.
Published: (2015)
by: Tan, Le Van, et al.
Published: (2015)
A generic assay for whole-genome amplification and deep sequencing of enterovirus A71
by: Le Van, Tan, et al.
Published: (2015)
by: Le Van, Tan, et al.
Published: (2015)
Partial protection against enterovirus 71 (EV71) infection in a mouse model immunized with recombinant newcastle disease virus capsids displaying the EV71 VP1 fragment.
by: Wei, Choong Ch'ng, et al.
Published: (2011)
by: Wei, Choong Ch'ng, et al.
Published: (2011)
Characterization of the adaptive immune responses in enterovirus a71 infection / Aw Yong Kam Leng
by: Aw, Yong Kam Leng
Published: (2016)
by: Aw, Yong Kam Leng
Published: (2016)
Novel Multiplex Oligonucleotide-Conjugated Bead Suspension Array for Rapid Identification of Enterovirus 71 Subgenogroups
by: Wu, Y., et al.
Published: (2011)
by: Wu, Y., et al.
Published: (2011)
Similar Items
-
Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor
by: Tan, Chee Wah, et al.
Published: (2013) -
In vitro evaluation of the antiviral activity of heparan sulfate mimetic compounds against Enterovirus 71
by: Pourianfar, Hamid Reza, et al.
Published: (2012) -
Development of novel miRNA-based vaccines and antivirals against Enterovirus 71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2016) -
Development of antivirals and vaccines against enterovirus 71 (EV-A71)
by: Poh, Chit Laa *
Published: (2018) -
Flavonoids as antiviral agents for Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2020)